Get PT-141 (Bremelanotide) Online in California | OmniRx Health
Sexual Wellness Treatment in California
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Key Benefits
- Works through the brain to enhance desire and arousal
- Effective for both men and women
- Addresses root causes of low libido rather than just physical response
- FDA-approved active ingredient (Vyleesi for women)
- Unique central mechanism distinct from PDE5 inhibitors
Who is a Good Candidate?
Men and women experiencing low sexual desire (HSDD), reduced libido, or sexual arousal difficulties who want a centrally-acting treatment that addresses desire rather than just the physical mechanics of sexual function.
Starting from $199/month
Serving California
From Silicon Valley innovators to Central Valley farmers, Californians deserve healthcare that fits their lifestyle. OmniRx Health serves the entire Golden State—whether you're navigating LA traffic, working remotely from Lake Tahoe, or managing a vineyard in Napa. Our telehealth platform brings world-class medical expertise directly to you, eliminating the need for lengthy commutes to crowded clinics in a state where time is precious.
OmniRx Health providers are licensed by the Medical Board of California, maintaining full compliance with state telehealth regulations.
We partner with California State Board of Pharmacy licensed pharmacies across LA, San Francisco, San Diego, and statewide for convenient prescription fulfillment.
California's Telehealth Advancement Act ensures broad access to virtual care, with recent legislation permanently expanding telehealth flexibilities established during the pandemic.
California mandates telehealth parity—insurers must cover virtual visits at the same rate as in-person appointments, including Medi-Cal and commercial plans.
Frequently Asked Questions
- How does PT-141 work differently from Viagra or Cialis?
- PDE5 inhibitors like sildenafil and tadalafil work by increasing blood flow to the genitals — they improve physical erectile function but do not enhance sexual desire. PT-141 activates melanocortin receptors in the brain that regulate sexual motivation and arousal, addressing the psychological and neurological dimension of sexual response that PDE5 inhibitors do not target.
- Can women use PT-141?
- Yes. PT-141 was originally developed in part to address hypoactive sexual desire disorder (HSDD) in women. Vyleesi (bremelanotide injection) is FDA-approved for premenopausal women with HSDD. It has also demonstrated benefits in men with situational erectile dysfunction related to low desire or performance anxiety.
- How and when is PT-141 administered?
- PT-141 is administered as a subcutaneous injection, typically 45 minutes to 2 hours before anticipated sexual activity to allow sufficient time for central nervous system activation. The injection site is typically the abdomen. Nausea is the most commonly reported side effect and is usually mild and temporary.
- Is telehealth legal in California?
- Yes, telehealth is fully legal and widely supported in California. The state has some of the most comprehensive telehealth laws in the nation, ensuring patients can access quality virtual care from licensed providers.
- Can I get controlled substances via telehealth in California?
- California allows telehealth providers to prescribe certain controlled substances following a proper evaluation. Our providers follow all DEA and state regulations for prescribing medications safely and legally.
- Does Medi-Cal cover telehealth in California?
- Yes, Medi-Cal covers telehealth services including video and audio-only visits. California has permanently expanded Medi-Cal telehealth coverage to ensure low-income residents have access to virtual care.